Jon Chambers

16.2k total citations · 4 hit papers
22 papers, 8.4k citations indexed

About

Jon Chambers is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Jon Chambers has authored 22 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Computational Theory and Mathematics and 5 papers in Pharmacology. Recurrent topics in Jon Chambers's work include Computational Drug Discovery Methods (9 papers), Receptor Mechanisms and Signaling (7 papers) and Adenosine and Purinergic Signaling (4 papers). Jon Chambers is often cited by papers focused on Computational Drug Discovery Methods (9 papers), Receptor Mechanisms and Signaling (7 papers) and Adenosine and Purinergic Signaling (4 papers). Jon Chambers collaborates with scholars based in United Kingdom, United States and Japan. Jon Chambers's co-authors include Anna Gaulton, Anne Hersey, John P. Overington, Mark Davies, Louisa J. Bellis, A. Patrícia Bento, Yvonne Light, Bissan Al‐Lazikani, David Michalovich and George Papadatos and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jon Chambers

22 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ChEMBL: a large-scale bioactivity database for drug discovery

2011 2.9k citations Anna Gaulton, Louisa J. Bellis et al. Nucleic Acids Research profile →
The ChEMBL database in 2017

2016 1.6k citations Anna Gaulton, Anne Hersey et al. Nucleic Acids Research profile →
The ChEMBL bioactivity database: an update

2013 1.1k citations A. Patrícia Bento, Anna Gaulton et al. Nucleic Acids Research profile →
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

2000 637 citations D Smart, Martin J. Gunthorpe et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon Chambers United Kingdom	19	4.8k	4.3k	1.4k	1.0k	976	22	8.4k
Didier Rognan France	53	6.3k 1.3×	3.8k 0.9×	910 0.7×	869 0.8×	1.0k 1.1×	173	8.9k
Steven Whitebread Switzerland	37	3.2k 0.7×	1.6k 0.4×	557 0.4×	162 0.2×	1.4k 1.5×	63	6.2k
Adriaan P. IJzerman Netherlands	66	13.9k 2.9×	2.6k 0.6×	935 0.7×	703 0.7×	5.7k 5.9×	470	21.3k
Christopher Southan United Kingdom	50	7.1k 1.5×	1.2k 0.3×	1.7k 1.2×	286 0.3×	2.3k 2.4×	120	15.5k
Millard H. Lambert United States	41	8.6k 1.8×	1.6k 0.4×	1.3k 0.9×	462 0.4×	988 1.0×	58	13.4k
Feixiong Cheng United States	60	7.7k 1.6×	6.1k 1.4×	1.1k 0.8×	833 0.8×	242 0.2×	195	13.8k
Paul D. Leeson United Kingdom	42	5.4k 1.1×	2.8k 0.7×	879 0.6×	451 0.4×	2.2k 2.3×	111	10.6k
Bissan Al‐Lazikani United Kingdom	30	8.0k 1.7×	3.7k 0.9×	793 0.6×	912 0.9×	828 0.8×	58	11.2k
Antti Poso Finland	41	2.7k 0.6×	1.3k 0.3×	916 0.7×	423 0.4×	516 0.5×	227	5.7k
Chris de Graaf Netherlands	46	5.0k 1.0×	1.8k 0.4×	388 0.3×	358 0.3×	1.8k 1.8×	139	6.7k

Countries citing papers authored by Jon Chambers

Since Specialization

Citations

This map shows the geographic impact of Jon Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Chambers more than expected).

Fields of papers citing papers by Jon Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Chambers. The network helps show where Jon Chambers may publish in the future.

Co-authorship network of co-authors of Jon Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Chambers. A scholar is included among the top collaborators of Jon Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Chambers. Jon Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Keller, Douglas A., Arianna Bassan, Alexander Amberg, et al.. (2023). In silico approaches in carcinogenicity hazard assessment: case study of pregabalin, a nongenotoxic mouse carcinogen. SHILAP Revista de lepidopterología. 5. 1234498–1234498. 4 indexed citations

2.

Gaulton, Anna, Anne Hersey, Michał Nowotka, et al.. (2016). The ChEMBL database in 2017. Nucleic Acids Research. 45(D1). D945–D954. 1589 indexed citations breakdown →

3.

Hersey, Anne, Jon Chambers, Louisa J. Bellis, et al.. (2015). Chemical databases: curation or integration by user-defined equivalence?. Drug Discovery Today Technologies. 14. 17–24. 34 indexed citations

4.

Papadatos, George, Mark Davies, Nathan Dedman, et al.. (2015). SureChEMBL: a large-scale, chemically annotated patent document database. Nucleic Acids Research. 44(D1). D1220–D1228. 150 indexed citations

5.

Chambers, Jon, Mark Davies, Anna Gaulton, et al.. (2014). UniChem: extension of InChI-based compound mapping to salt, connectivity and stereochemistry layers. Journal of Cheminformatics. 6(1). 43–43. 24 indexed citations

6.

Chambers, Jon, Mark Davies, Anna Gaulton, et al.. (2013). UniChem: a unified chemical structure cross-referencing and identifier tracking system. Journal of Cheminformatics. 5(1). 3–3. 115 indexed citations

7.

Bento, A. Patrícia, Anna Gaulton, Anne Hersey, et al.. (2013). The ChEMBL bioactivity database: an update. Nucleic Acids Research. 42(D1). D1083–D1090. 1117 indexed citations breakdown →

8.

Gaulton, Anna, Louisa J. Bellis, A. Patrícia Bento, et al.. (2011). ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Research. 40(D1). D1100–D1107. 2947 indexed citations breakdown →

9.

Moore, Darren J., Jon Chambers, Paul R. Murdock, & P.C. Emson. (2002). Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor. Neuropharmacology. 43(6). 966–978. 14 indexed citations

10.

Charlton, Steven J., et al.. (2001). EXPRESSION AND FUNCTIONAL ANALYSIS OF CHEMOKINE RECEPTORS IN HUMAN PERIPHERAL BLOOD LEUKOCYTE POPULATIONS. Cytokine. 14(1). 27–36. 68 indexed citations

11.

Duckworth, Malcolm, Paul R. Murdock, Cibele Sabido-David, et al.. (2001). Molecular Cloning and Functional Characterization of MCH2, a Novel Human MCH Receptor. Journal of Biological Chemistry. 276(23). 20125–20129. 186 indexed citations

12.

Moore, Darren J., Jon Chambers, K. B. Tan, et al.. (2001). Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription–polymerase chain reaction study. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1521(1-3). 107–119. 122 indexed citations

13.

Moore, Darren J., Shuji Iritani, Jon Chambers, & Piers C. Emson. (2000). Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimerʼs disease. Neuroreport. 11(17). 3799–3803. 56 indexed citations

14.

Elshourbagy, Nabil A., Robert S. Ames, Laura R. Fitzgerald, et al.. (2000). Receptor for the Pain Modulatory Neuropeptides FF and AF Is an Orphan G Protein-coupled Receptor. Journal of Biological Chemistry. 275(34). 25965–25971. 226 indexed citations

15.

Moore, Darren J., Jon Chambers, Henry J. Waldvogel, Richard L. M. Faull, & Piers C. Emson. (2000). Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: Striking neuronal localisation. The Journal of Comparative Neurology. 421(3). 374–384. 126 indexed citations

16.

Smart, D, Martin J. Gunthorpe, Jeffrey C. Jerman, et al.. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). British Journal of Pharmacology. 129(2). 227–230. 637 indexed citations breakdown →

17.

Szekeres, Philip, Alison I. Muir, Jane Miller, et al.. (2000). Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3. Journal of Biological Chemistry. 275(27). 20247–20250. 145 indexed citations

18.

Sarau, Henry M., Robert S. Ames, Jon Chambers, et al.. (1999). Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor. Molecular Pharmacology. 56(3). 657–663. 12 indexed citations

19.

Chambers, Jon, Robert S. Ames, Derk J. Bergsma, et al.. (1999). Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature. 400(6741). 261–265. 413 indexed citations

20.

Sarau, Henry M., Robert S. Ames, Jon Chambers, et al.. (1999). Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor. Molecular Pharmacology. 56(3). 657–663. 286 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact